-74% Off

Gefitero 250mg Tablet

Original price was: ₹2,532.80.Current price is: ₹650.00.

Gefitero Tablet helps treat non-small cell lung cancer, or NSCLC, when the cancer has moved to other areas of the body. Doctors give it to patients who carry EGFR gene mutations and have not started any earlier treatments for their cancer.

Product Details

Salt/Formula: Gefitinib (250mg)

Manufacturer: Hetero Healthcare ltd

Dosage: 250mg

Doctor's Prescription Required for this Product.
WhatsApp Enquiry Compare
Weight/Quantity: 10 tablet in 1 box

Store below 30°C

Benefits

Gefitero Tablet helps treat non-small cell lung cancer. It works for both smokers and non-smokers in that condition. Doctors often give it on its own or mix it with other medications to fight the disease. This is a powerful type of cancer drug, so you really need to go over the risks and benefits with your doctor before starting. During the whole treatment period, stay away from alcohol and keep yourself well hydrated by drinking enough fluids.

How to Use

Follow your doctor’s exact instructions for this medication. Take it in the dose they recommend and for the full time they specify.

Specification

Follow your doctor’s exact instructions for this medication. Take it in the dose they recommend and for the full time they specify.

Side Effects

The common side effects you might see with Gefitero include diarrhea, dry skin, loss of appetite, nausea, rash, mouth sores, vomiting, weakness, and weight loss. Most of these side effects stay pretty mild.

They tend to fade as your body gets adjusted to the medicine.

Still, you should check with your doctor if any of them last too long or start to bother you.

Description

Gefitero Tablet treats non-small cell lung cancer, or NSCLC, when the disease has spread to other areas in the body. Doctors give it to patients carrying EGFR gene mutations who still have not tried any earlier cancer therapies.

Reviews

There are no reviews yet.

Be the first to review “Gefitero 250mg Tablet”

Your email address will not be published. Required fields are marked *